Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,842 | 93 | 99.3% |
| Education | $12.70 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $363.55 | 24 | $0 (2024) |
| Allergan Inc. | $224.25 | 14 | $0 (2019) |
| Janssen Biotech, Inc. | $204.02 | 11 | $0 (2023) |
| Gilead Sciences, Inc. | $162.04 | 9 | $0 (2024) |
| Stryker Corporation | $147.09 | 1 | $0 (2022) |
| Shionogi Inc | $122.06 | 5 | $0 (2024) |
| Genentech USA, Inc. | $119.90 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $104.61 | 5 | $0 (2023) |
| Melinta Therapeutics, LLC | $99.78 | 4 | $0 (2020) |
| Theratechnologies Inc. | $61.18 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.92 | 5 | Shionogi Inc ($51.19) |
| 2023 | $397.95 | 18 | Merck Sharp & Dohme LLC ($94.44) |
| 2022 | $261.99 | 7 | Stryker Corporation ($147.09) |
| 2020 | $63.70 | 4 | Merck Sharp & Dohme Corporation ($26.78) |
| 2019 | $275.75 | 17 | Merck Sharp & Dohme Corporation ($81.95) |
| 2018 | $352.24 | 24 | Janssen Biotech, Inc. ($67.34) |
| 2017 | $396.32 | 19 | Allergan Inc. ($126.24) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/09/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/15/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.69 | General |
| 02/26/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/13/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: COVID-19 | ||||||
| 10/09/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: COVID-19 | ||||||
| 09/07/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: COVID-19 | ||||||
| 06/07/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/22/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/29/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/24/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/13/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/10/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/24/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/13/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Respiratory | ||||||
| 03/09/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.88 | General |
| 02/06/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/30/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Infectious Diseases | ||||||
| 01/09/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/20/2022 | Stryker Corporation | STRYKER NAV3 (Device) | Food and Beverage | In-kind items and services | $147.09 | General |
| Category: NAVIGATION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 15 | 44 | $9,416 | $3,519 |
| 2021 | 3 | 35 | 98 | $18,977 | $6,478 |
| 2020 | 3 | 42 | 100 | $23,716 | $9,246 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 44 | $9,416 | $3,519 | 37.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 40 | $8,560 | $3,029 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 47 | $7,755 | $2,523 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 11 | $2,662 | $926.09 | 34.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 77 | $16,478 | $6,406 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $4,334 | $1,804 | 41.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 12 | $2,904 | $1,035 | 35.7% |
About Dr. John Johnson, MD
Dr. John Johnson, MD is a Infectious Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831119593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Johnson, MD has received a total of $1,855 in payments from pharmaceutical and medical device companies, with $106.92 received in 2024. These payments were reported across 94 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,842).
As a Medicare-enrolled provider, Johnson has provided services to 92 Medicare beneficiaries, totaling 242 services with total Medicare billing of $19,243. Data is available for 3 years (2020–2022), covering 7 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Cleveland, OH
- Active Since 07/19/2006
- Last Updated 11/23/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1831119593
Products in Payments
- ZERBAXA (Drug) $164.03
- STRYKER NAV3 (Device) $147.09
- AVYCAZ (Drug) $127.79
- Fetroja (Drug) $122.06
- SYMTUZA (Drug) $108.53
- DIFICID (Drug) $108.00
- Cresemba (Drug) $104.61
- Vabomere (Drug) $99.78
- TEFLARO (Drug) $89.46
- Veklury (Drug) $69.00
- PREZCOBIX (Drug) $67.34
- Arikayce (Drug) $54.37
- PIFELTRO (Drug) $50.99
- DALVANCE (Drug) $43.34
- NOXAFIL (Drug) $40.53
- TROGARZO (Drug) $35.00
- Xerava (Drug) $31.80
- Symtuza (Drug) $28.15
- EGRIFTA (Drug) $26.18
- SYMBICORT (Drug) $19.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Cleveland
Steven Gordon, Md, MD
Infectious Disease — Payments: $161,172
Melissa Jenkins, Md, MD
Infectious Disease — Payments: $159,244
Grace Mccomsey, Md, MD
Infectious Disease — Payments: $125,254
Alan Jay Taege, Md, MD
Infectious Disease — Payments: $107,534
Dr. Robin Jump, Md, Phd, MD, PHD
Infectious Disease — Payments: $56,857
Dr. Robert Bonomo, Md, MD
Infectious Disease — Payments: $52,004